Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Sep 1;41(3):351-355.
doi: 10.1097/WNO.0000000000001348.

A Case of Post-COVID-19-Associated Paracentral Acute Middle Maculopathy and Giant Cell Arteritis-Like Vasculitis

Go L Jonathan  1 , Fair M Scott, Kay D Matthew
Affiliations
Case Reports

A Case of Post-COVID-19-Associated Paracentral Acute Middle Maculopathy and Giant Cell Arteritis-Like Vasculitis

Go L Jonathan et al. J Neuroophthalmol. .

Abstract

A 47-year-old man with a history of COVID-19 infection 2 months before presentation, presented with a scotoma of the paracentral visual field of the right eye. After thorough testing and evaluation, a diagnosis of paracentral acute middle maculopathy (PAMM) was established. Two months later, the patient developed temporal headache and jaw claudication. High-dose steroids were initiated, and workup for giant cell arteritis (GCA) was undertaken. The patient experienced resolution of the symptoms within 24 hours of steroid initiation. ESR, CRP, and temporal artery biopsy results were normal, although all were obtained more than 2 weeks after steroid initiation. To the best of our knowledge, our patient represents the first individual to date to potentially implicate COVID-19 in both small and large vessel vasculitis in the ophthalmic setting.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

References

    1. Virgo J, Mohamed M. Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection. Eye (Lond). 2020;34:2352–2353.
    1. Gascon P, Briantais A, Bertrand E, Ramtohul P, Comet A, Beylerian M, Sauvan L, Swiader L, Durand JM, Denis D. Covid-19-associated retinopathy: a case report. Ocul Immunol Inflamm. 2020;28:1293–1297.
    1. Quintana-Castanedo L, Feito-Rodríguez M, Fernández-Alcalde C, Granados-Fernández M, Montero-Vega D, Mayor-Ibarguren A, de Lucas-Laguna R. Concurrent chilblains and retinal vasculitis in a child with COVID-19. J Eur Acad Dermatol Venereol. 2020;34:e764–e766.
    1. Riera-Martí N, Romaní J, Calvet J. SARS-CoV-2 infection triggering a giant cell arteritis. Med Clin (Barc). 2021;156:253–254.
    1. Becker RC. COVID-19 update: covid-19-associated coagulopathy. J Thromb Thrombolysis. 2020;50:54–67.

Publication types